Latest News & Updates

Biologics Contribute to Growth in Pharma Products Cold-Chain Market

In its September issue, Pharmaceutical Commerce details the previous and expected contributions of biologic products to its forecast of cold-chain market growth predicting sales of cold-chain drugs and biologics will outpace overall industry growth through 2022. It is reported that “as of 2018, global...

Wednesday, September 12, 2018 | Read More

FDA Researchers Explore Fundamental Chemical Reaction that Could Threaten the Quality of Therapeutic Protein Products

In a recent news release the FDA described research it has conducted regarding detection of protein carbonylation, an oxidative reaction that may occur in therapeutic protein drug products during manufacture, storage, use, and transport potentially causing structural alterations and threatening stability,...

Tuesday, September 11, 2018 | Read More

Sentry representatives attend DCAT week

Sentry BioPharma Services is pleased to announce delegates from Sentry’s Business Development team will be in New York City attending the Drug, Chemical & Associated Technologies Association (DCAT) Week March 19th -22nd. The four-day conference brings together key sourcing, procurement and business...

Monday, March 19, 2018 | Read More

Vaccine Storage & Distribution

Vaccine Cold Chain Solutions: Timely Fulfillment of Seasonal and Stockpile Requirements

Secure vaccine storage and distribution services protect your inventory throughout the supply chain. Sentry’s guardianship ensures proper vaccine storage, rotation, accurate tracking and proper distribution of vaccines for routine fulfillment or pandemic response. Standard operating procedures (SOPs) and validated cold chain storage environments minimize time-out-of-refrigeration (TOR) risks, helping to reduce or eliminate waste attributable to inadequate storage methods. Flexible storage options help fulfill requirements for specific seasonal or stockpile campaigns. Vaccine manufacturers and healthcare organizations concerned with drug product integrity, supply chain security, risk management or timely distribution should consider a partnership with Sentry. Sentry’s vaccine program advantages include:

 

  • Compliant vaccine storage, rotation and distribution solutions
  • Advanced inventory management systems
  • Advanced building management systems that monitor and control temperature of storage environments
  • Trusted by hospitals, government healthcare agencies, and manufacturers to protect vaccine products and stockpiles

 

 

  

For more information about how Sentry's proven vaccine management system can protect your vaccine throughout the global supply chain, contact Sentry via email or by phone at 1-866-757-7400.